Literature DB >> 25801447

Oxaliplatin-induced neuropathy: a tale of two electrolytes.

Hani M Babiker1, Myke R Green, Mark A Nelson, Emad Elquza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25801447     DOI： 10.1007/s00520-015-2702-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  15 in total

1.  Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

Authors:  Axel Grothey; Daniel A Nikcevich; Jeff A Sloan; John W Kugler; Peter T Silberstein; Todor Dentchev; Donald B Wender; Paul J Novotny; Umesh Chitaley; Steven R Alberts; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

2.  Calcium/magnesium infusion for oxaliplatin-induced neuropathy: protective or not?

Authors:  Abolfazl Avan; Amir Avan; Elisa Giovannetti; Godefridus J Peters
Journal:  J Clin Oncol       Date:  2014-08-18       Impact factor: 44.544

3.  Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.

Authors:  Carl D Atkins
Journal:  J Clin Oncol       Date:  2014-08-18       Impact factor: 44.544

Review 4.  Oxaliplatin: mechanism of action and antineoplastic activity.

Authors:  E Raymond; S Faivre; J M Woynarowski; S G Chaney
Journal:  Semin Oncol       Date:  1998-04       Impact factor: 4.929

5.  Lhermitte sign and urinary retention: atypical presentation of oxaliplatin neurotoxicity in four patients.

Authors:  Sarah Taieb; Véronique Trillet-Lenoir; Loïc Rambaud; Louis Descos; Gilles Freyer
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

6.  The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons.

Authors:  H Adelsberger; S Quasthoff; J Grosskreutz; A Lepier; F Eckel; C Lersch
Journal:  Eur J Pharmacol       Date:  2000-10-06       Impact factor: 4.432

Review 7.  Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.

Authors:  May T Aziz; Brittany L Good; Denise K Lowe
Journal:  Ann Pharmacother       Date:  2014-02-27       Impact factor: 3.154

8.  Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.

Authors:  Mohab M Ibrahim; Hongfeng Deng; Alexander Zvonok; Debra A Cockayne; Joyce Kwan; Heriberto P Mata; Todd W Vanderah; Josephine Lai; Frank Porreca; Alexandros Makriyannis; T Philip Malan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

9.  Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer.

Authors:  Laurence Gamelin; Michele Boisdron-Celle; Remy Delva; Véronique Guérin-Meyer; Norbert Ifrah; Alain Morel; Erick Gamelin
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

10.  A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain.

Authors:  Cristina Nativi; Roberta Gualdani; Elisa Dragoni; Lorenzo Di Cesare Mannelli; Silvia Sostegni; Martina Norcini; Gabriele Gabrielli; Giancarlo la Marca; Barbara Richichi; Oscar Francesconi; Maria Rosa Moncelli; Carla Ghelardini; Stefano Roelens
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379
View more
  1 in total

1.  Emotional distress and quality of life during folinic acid, fluorouracil, and oxaliplatin in colorectal cancer patients with and without chemotherapy-induced peripheral neuropathy: A cross-sectional study.

Authors:  Hsin-Tien Hsu; Li-Min Wu; Pei-Chao Lin; Chiung-Hui Juan; Yu-Yen Huang; Pi-Ling Chou; Jyu-Lin Chen
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.